ClinConnect ClinConnect Logo
Search / Trial NCT06240897

CURATE.Dtx as a Diagnostic and Management Tool for Delirium

Launched by INSTITUTE FOR DIGITAL MEDICINE (WISDM) · Jan 31, 2024

Trial Information

Current as of May 19, 2025

Not yet recruiting

Keywords

Digital Health Digital Diagnostic

ClinConnect Summary

The CURATE.DTx trial is studying a new tool designed to help detect and manage delirium, a serious condition that can affect older patients in the hospital. This tool is a fun and interactive game played on a tablet, which uses smart technology to adjust the game's difficulty based on each player's needs. The goal of the study is to see how well this game works for screening and helping patients who are at risk for delirium while they are hospitalized.

To be eligible to participate in this trial, you need to be at least 65 years old and admitted to the medical ward at SGH, with a life expectancy of at least one month. Unfortunately, pregnant or breastfeeding women, those who can't use tablets due to physical limitations, or individuals who do not understand English won't be able to join. If you take part in the trial, you can expect to use this innovative game while receiving care in the hospital, and your feedback will help improve how delirium is managed in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Admitted to the medical ward in SGH
  • Age \>=65 years old
  • Patients with a life expectancy of at least 1 month
  • Exclusion Criteria:
  • Pregnant or breastfeeding women
  • Patients physically incapable of using computer tablets (either due to vision loss or dominant hand weakness)
  • Patients who cannot understand spoken the English language.
  • Patients who are unable to give informed consent.

About Institute For Digital Medicine (Wisdm)

The Institute for Digital Medicine (WisDM) is a leading research organization dedicated to advancing the field of digital health through innovative clinical trials and studies. With a focus on integrating cutting-edge technology and data analytics, WisDM aims to enhance patient outcomes and streamline healthcare delivery. The institute collaborates with healthcare providers, academic institutions, and technology partners to develop evidence-based solutions that leverage digital tools for improved treatment and prevention strategies. Committed to ethical research practices and regulatory compliance, WisDM strives to contribute valuable insights to the evolving landscape of digital medicine.

Locations

Singapore, , Singapore

Singapore, , Singapore

Patients applied

0 patients applied

Trial Officials

Dean Ho, PhD

Principal Investigator

The Institute for Digital Medicine (WisDM)

Esther M Fan Peijin

Principal Investigator

Singapore General Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported